DEPUY ASR XL FEM IMP SIZE 49
Report
- Report Number
- 1818910-2014-22681
- Event Type
- Injury
- Date Received
- July 3, 2014
- Date of Event
- April 15, 2014
- Report Date
- November 7, 2014
- Manufacturer
- DEPUY INTERNATIONAL LTD. 8010379
- Product Code
- KXA
- Removal / Correction Number
- Z-1749/1816-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PATIENT
Narratives
IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.
IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
ASR REVISION. RIGHT. ASR XL. REASON(S) FOR REVISION: PERIPROSTHETIC FRACTURE. UPDATE RECEIVED 7TH NOVEMBER 2014. TAPER SLEEVE ADDED. EXPIRY DATES ADDED. COMPLAINT CATEGORIES AMENDED - FRACTURE WAS OF BONE, NOT IMPLANT.
ASR REVISION, RIGHT, ASR XL, REASON(S) FOR REVISION: PERIPROSTHETIC FRACTURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 389511 | DEPUY ASR XL FEM IMP SIZE 49 | HIP FEMORAL HEAD | KXA | DEPUY INTERNATIONAL LTD. 8010379 | 2381687 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |